EP1225866A4 - Procede et compositions pour traiter des maladies respiratoires - Google Patents

Procede et compositions pour traiter des maladies respiratoires

Info

Publication number
EP1225866A4
EP1225866A4 EP00975533A EP00975533A EP1225866A4 EP 1225866 A4 EP1225866 A4 EP 1225866A4 EP 00975533 A EP00975533 A EP 00975533A EP 00975533 A EP00975533 A EP 00975533A EP 1225866 A4 EP1225866 A4 EP 1225866A4
Authority
EP
European Patent Office
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00975533A
Other languages
German (de)
English (en)
Other versions
EP1225866A2 (fr
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1225866A2 publication Critical patent/EP1225866A2/fr
Publication of EP1225866A4 publication Critical patent/EP1225866A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne le traitement de maladies respiratoires telles que la maladie respiratoire obstructive chronique ou l'asthme par l'administration d'un inhibiteur de phosphodiestérase 4 en combinaison avec un corticostéroïde anti-inflammatoire.
EP00975533A 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires Withdrawn EP1225866A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
US163158P 1999-11-02
PCT/US2000/030113 WO2001032127A2 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires

Publications (2)

Publication Number Publication Date
EP1225866A2 EP1225866A2 (fr) 2002-07-31
EP1225866A4 true EP1225866A4 (fr) 2004-04-21

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00975533A Withdrawn EP1225866A4 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires

Country Status (29)

Country Link
EP (1) EP1225866A4 (fr)
JP (1) JP2003513028A (fr)
KR (1) KR20020057988A (fr)
CN (1) CN1387404A (fr)
AP (1) AP2002002496A0 (fr)
AR (1) AR029189A1 (fr)
AU (1) AU1357501A (fr)
BG (1) BG106748A (fr)
BR (1) BR0015270A (fr)
CA (1) CA2388333A1 (fr)
CO (1) CO5261512A1 (fr)
CZ (1) CZ20021512A3 (fr)
DZ (1) DZ3225A1 (fr)
EA (1) EA200200518A1 (fr)
EC (1) ECSP003747A (fr)
HK (1) HK1049107A1 (fr)
HU (1) HUP0203152A3 (fr)
IL (1) IL149367A0 (fr)
MA (1) MA26841A1 (fr)
MX (1) MXPA02004350A (fr)
NO (1) NO20022057L (fr)
OA (1) OA12076A (fr)
PE (1) PE20011005A1 (fr)
PL (1) PL355261A1 (fr)
SK (1) SK7592002A3 (fr)
TR (1) TR200201211T2 (fr)
TW (1) TWI242431B (fr)
WO (1) WO2001032127A2 (fr)
ZA (1) ZA200203435B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459757C (fr) * 2001-09-19 2011-08-30 Altana Pharma Ag Combinaison
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (fr) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. Composition therapeutique
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (fr) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Traitements prophylactiques ou therapeutiques de maladie chronique de la peau
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (fr) 2013-10-30 2015-05-07 Wockhardt Limited Compositions pharmaceutiques comprenant une combinaison de roflumilast et d'acébrophylline ou de leurs sels pharmaceutiquement acceptables

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000139A1 (fr) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Composes
DE4332041A1 (de) * 1993-09-21 1995-03-23 Rentschler Arzneimittel Verwendung von Pentoxifyllin zur Behandlung granulomatöser und fibrosierender Lungenerkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000139A1 (fr) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Composes
DE4332041A1 (de) * 1993-09-21 1995-03-23 Rentschler Arzneimittel Verwendung von Pentoxifyllin zur Behandlung granulomatöser und fibrosierender Lungenerkrankungen

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MURDOCH R ET AL: "The addition of SB 207499 (ARIFLO), a novel and selective PDE4 inhibitor, to oral prednisolone, is safe and well tolerated", EUROPEAN RESPIRATORY JOURNAL, vol. 12, no. SUPPL. 28, September 1998 (1998-09-01), European Respiratory Society Annual Congress;Geneva, Switzerland; September 19-23, 1998, pages 362S, XP009026674, ISSN: 0903-1936 *
NORMAN P: "PDE4 inhibitors 1999", EXPERT OPINION ON THERAPEUTIC PATENTS 1999 UNITED KINGDOM, vol. 9, no. 8, 1999, pages 1101 - 1118, XP001058161, ISSN: 1354-3776 *
SILVESTRE J ET AL: "SB-207499. Antiasthmatic/antiinflammatory phosphodiesterase IV inhibitor", DRUGS OF THE FUTURE 1998 SPAIN, vol. 23, no. 6, 1998, pages 607 - 615, XP000981875, ISSN: 0377-8282 *
TORPHY T J ET AL: "ARIFLO (SB 207499), A SECOND GENERATION PHOSPHODIESTERASE 4 INHIBITOR FOR THE TREATMENT OF ASTHMA AND COPD: FROM CONCEPT TO CLINIC", PULMONARY PHARMACOLOGY AND THERAPEUTICS, ACADEMIC PRESS, NEW YORK, NY, US, vol. 12, no. 2, 1999, pages 131 - 135, XP001155797, ISSN: 1094-5539 *

Also Published As

Publication number Publication date
CN1387404A (zh) 2002-12-25
AR029189A1 (es) 2003-06-18
WO2001032127A3 (fr) 2001-12-06
TWI242431B (en) 2005-11-01
PL355261A1 (en) 2004-04-05
OA12076A (en) 2006-05-04
JP2003513028A (ja) 2003-04-08
IL149367A0 (en) 2002-11-10
HK1049107A1 (zh) 2003-05-02
PE20011005A1 (es) 2001-09-28
NO20022057D0 (no) 2002-04-30
ECSP003747A (es) 2002-05-23
CO5261512A1 (es) 2003-03-31
AU1357501A (en) 2001-05-14
CZ20021512A3 (cs) 2003-04-16
SK7592002A3 (en) 2002-11-06
CA2388333A1 (fr) 2001-05-10
KR20020057988A (ko) 2002-07-12
WO2001032127A2 (fr) 2001-05-10
NO20022057L (no) 2002-06-27
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
HUP0203152A3 (en) 2004-06-28
BG106748A (en) 2003-02-28
MA26841A1 (fr) 2004-12-20
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
DZ3225A1 (fr) 2001-05-10
BR0015270A (pt) 2002-06-18
EP1225866A2 (fr) 2002-07-31
ZA200203435B (en) 2003-06-25
AP2002002496A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
WO2003011274A3 (fr) Methode therapeutique
WO2003000241A3 (fr) Nouvelles compositions de medicament a base d'anticholinergiques, de corticosteroides et d'agents beta-mimetiques
WO2004078144A3 (fr) Composes diphenylethylene et leurs utilisations
WO2004021989A3 (fr) Imidazolopyridines, procedes de fabrication et methodes d'utilisation
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2003051380A3 (fr) Composition destinee au traitement de troubles neurocerebrovasculaires
WO2004078712A3 (fr) Derives d'isoquinoline et leurs methodes d'utilisation
WO2005009349A3 (fr) Composition et methode pour traiter des troubles neurologiques
BR9913152A (pt) Terapias para tratamento de doenças pulmonares
IS6444A (is) Pýrimidín karboxamíð nytsamleg sem latar á PDE4 samsætuensím
AU2003235613A1 (en) Crude drug compositions for treating or preventing arthritic diseases and the preparation process
IL100905A0 (en) Pharmaceutical compositions for treatment of pulmonary inflammation
WO2002002565A3 (fr) Agents anti-inflammatoires a selectivite glucocortiocoide
WO2003047577A3 (fr) Compositions pharmaceutiques et utilisations associees
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
BR0009446A (pt) Composto, processo para preparar o mesmo, composição uso de um composto, e, métodos para o tratamento ou a prevenção de uma doença em um mamìfero, para o tratamento ou a prevenção de asma em um mamìfero e para o tratamento ou a prevenção de doença pulmonar obstrutiva crÈnica em um mamìfero
WO2002004421A3 (fr) Analogues de pyridoxine et de pyridoxal utilises comme agents de therapie cardio-vasculaire
WO2001032127A3 (fr) Procede et compositions pour traiter des maladies respiratoires
WO2004043456A8 (fr) Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination
WO2005032470A3 (fr) Compositions et methodes de traitement de brulures
WO1999012933A3 (fr) Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase
WO2003039464A3 (fr) Aerosol antimuscarinique
WO2006015970A3 (fr) Medicaments pour la prevention ou le traitement de la pneumonie alveolaire comprenant un anticholinergique
AU2003272945A1 (en) Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction
WO2005011608A3 (fr) Combinaison de deshydroepiandrosterone ou deshydroepiandrosterone-sulfate avec un derive de methylxanthine pour le traitement de l'asthme ou de maladie pulmonaire obstructive chronique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020521

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20020521

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 43/36 A, 7A 61K 31/40 B, 7A 61K 31/56 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040304

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31:44 O

Ipc: 7A 61K 31/575 K

Ipc: 7A 61K 31/575 M

Ipc: 7A 61K 31:44 N

Ipc: 7A 61K 31:275 K

Ipc: 7A 61P 11/00 B

Ipc: 7A 61K 31/575 A

Ipc: 7A 61K 31/4439 B

Ipc: 7A 61K 31:4439 L

Ipc: 7A 61K 31/44 B

Ipc: 7A 61K 31/58 L

Ipc: 7A 61K 31/58 J

Ipc: 7A 61K 31:4439 M

Ipc: 7A 61K 31/58 N

Ipc: 7A 61K 31/58 B

Ipc: 7A 61K 31:275 J

Ipc: 7A 61K 31/275 B

Ipc: 7A 61K 31/575 O

17Q First examination report despatched

Effective date: 20070111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070523

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1049107

Country of ref document: HK